pembrolizumab is better than ipilimumab for advanced melanoma in phase iii trial
Published 9 years ago • 1.1K plays • Length 24:18Download video MP4
Download video MP3
Similar videos
-
5:37
phase iii trial shows pembrolizumab preferable to ipilimumab in advanced melanoma
-
6:51
success for ipilimumab and nivolumab combo in advanced melanoma
-
0:37
tils prolong pfs compared with pembrolizumab in advanced melanoma
-
3:35
keynote-006: the efficacy of ipilimumab after pembrolizumab in patients with advanced melanoma
-
2:34
keynote-029: pembrolizumab with ipilimumab for melanoma
-
3:52
pembrolizumab and indoximod for melanoma
-
4:07
phase ii trial of ipilimumab-nivolumab combo shows promise in advanced melanoma
-
3:16
#esmo22 highlights on tils versus ipilimumab in patients with advanced melanoma: the phase 3 study
-
7:50
keynote-598: pembrolizumab with ipilimumab or placebo in patients with untreated metastatic nsclc
-
5:30
what is the relationship between pd-l1 expression and antitumor activity?
-
3:31
comment: adjuvant ipilimumab in high-risk melanoma
-
3:46
phase iii trial: pembrolizumab for patients w/ metastatic nsclc that expresses pd-1
-
2:48
checkmate067 outcomes: nivolumab plus ipilimumab in advanced melanoma
-
2:57
neoadjuvent ipilimumab plus nivolumab beneficial compared to adjuvent nivolumab in macroscopic, ...
-
3:13
latest data from keynote 42: pembrolizumab vs chemotherapy in treatment-naive patients (pts) wit...
-
3:59
checkmate 067 - combined nivolumab and ipilimumab
-
3:39
keynote-716: pembrolizumab for patients with high-risk stage ii melanoma
-
5:18
neoadjuvant ipilimumab and nivolumab immunotherapy for resectable stage iii melanoma
-
4:50
comment: reasonable to conclude that pembrolizumab is non-inferior to chemotherapy